← Leaderboards
Claire Acevedo
University Of Utah
$161,829
Attributed
$323,657
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $187.3K · FY2021–22$200K$150K$100K$50K$0
'21
'22
Funding mix
By agency
NIH$323,657 · 1
By mechanism
R21$323,657 · 1
Top collaborators
- David Kammer2 shared
Most similar at University Of Utah
Same institution · by research overlap
- Jeffrey A. Weiss$16,889,073
- Kota Takahashi$3,368,587
- Natalya Y Rapoport$2,983,111
- David H Viskochil$1,815,146
- Yihua Bruce Yu$3,983,190
Others in their field
Other Emerging Leaders on “Advanced Glycosylation End Products”
- Raja G Khalifah · Praetego, Inc.$5,752,037
- Colleen Bauza · Jaeb Center For Health Research, Inc.$4,053,339
- Viral N Shah · University Of Colorado Denver$2,628,424
- Guowei Su · Glycan Therapeutics Corporation$2,405,945
- Malia Michelle Edwards · Johns Hopkins University$2,372,735
- Maria Luiza A Caramori · University Of Minnesota$2,306,563
Research focus
Advanced Glycosylation End ProductsAffectAmericanBehaviorBiomechanicsBlood GlucoseBoneBone FragilityBone MassBone QualityBone StructureCattleCellsCollagenCollagen FibrilComplexComplicationComputer ModelsConsumptionCortical BoneCrosslinkDensityDiabetes MellitusAdult